The IPO Buzz: Biotechs Bicara Therapeutics (BCAX) & Zenas BioPharma (ZBIO) On the Front Burner
Two biotechs – Bicara Therapeutics (BCAX Proposed) and Zenas BioPharma (ZBIO Proposed) – lead the IPO Calendar this week – the week of Sept. 9, 2024 – with plans to raise about $200 million each. Both IPOs are similar in size: Each company plans to offer about 11.8 million shares at a price range of […]
September 8, 2024 Read More